ANIMATE: A PHASE II STUDY OF NIVOLUMAB IN TRANSPLANT ELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA

Booth S, Kirkwood A, Johnson P, Barrington S, Gallop‐Evans E, Peggs K, Warbey V, Burton C, Ardavan A, Phillips B, Lawrie E, Pike L
,
et al
No abstract available
Keywords:

32 Biomedical and Clinical Sciences

,

3201 Cardiovascular Medicine and Haematology

,

3211 Oncology and Carcinogenesis

,

Lymphoma

,

Hodgkin's Disease

,

Clinical Trials and Supportive Activities

,

Rare Diseases

,

Transplantation

,

Cancer

,

Hematology

,

Lymphatic Research

,

Clinical Research

,

Cancer